Arachidonic Acid Inhibits Cysteinyl-Leukotriene Receptor Activation in Human Pulmonary Vessels

  • Laurence Walch
  • Xavier Norel
  • Jean-Pierre Gascard
  • Charles Brink
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 525)


There are a few reports suggesting that arachidonic acid may have direct regulatory actions in cells or tissues which are independent of the released endogenous metabolites. Brotherton and co-workers [1] reported that endothelial cells in culture which released prostacyclin in the presence of arachidonic acid became refractory subsequent to a second stimulation, that is, the cells failed to release significant levels of prostacyclin when compared with the initial challenge. These observations were also supported by the work of Revtyak and co-workers [2] who demonstrated that both histamine- and A23187-induced prostacyclin release was inhibited in human endothelial cells subsequent to arachidonic acid exposure. These results suggested that arachidonic acid may play a direct regulatory role via interaction with cell surface receptors. The aim of this investigation was to examine the effects of arachidonic acid on human pulmonary arteries and veins by measuring the release of several metabolites subsequent to the arachidonic acid exposure and evaluate the effects of cysteinyl-leukotrienes on this release.


Arachidonic Acid Human Endothelial Cell Prostacyclin Production Intact Preparation Coronary Arterial Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brotherton AFA, Hoak JC. Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygénase. J Clin Invest 1983; 72: 1255–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Revtyak GE, Johnson AR, Campbell WB. Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. Am J Physiol 1988; 254:C8–C19.PubMedGoogle Scholar
  3. 3.
    Bessard J, Cracowski J-L, Stanke-Labesque F, Bessard G. Determination of isoprostaglandin F type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatog 2001; B 754: 333–43.Google Scholar
  4. 4.
    Dejana E, Balconi G, De Castellarnau C, Barbieri B, Vergara-Dauden M, De Gaetano G. Prostacyclin production by human endothelial and bovine smooth muscle cells in culture. Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A23187. Biochim Biophys Acta 1983; 750: 261–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Mehta J, Mehta P, Ostrowski N. Effects of different amounts of arachidonic acid on vessel wall generated PGI2 and TXA2. Prostaglandins Leukot Med 1983; 12:253–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Jen CJ, Huang TY, Chen HI, Wing LYC, Lin MT, Wu HL, Chang WC. Regional differences in prostacyclin production rates among porcine intrathoracic vessels. Prostaglandins 1994; 47: 109–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Cramer EB, Pologe L, Pawlowski NA, Cohn ZA, Scott WA. Leukotriene C promotes prostacyclin synthesis by human endothelial cells. Proc Natl Acad Sci USA 1983; 80: 4109–13.PubMedCrossRefGoogle Scholar
  8. 8.
    Bäck M, Norel X, Walch L, Gascard J-P, de Montpreville V, Dahlén S-E, Brink C. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. Eur J Pharmacol 2000; 401: 389–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Hresko RC, Hoffman RD, Flores-Riveros JR, Lane MD. Insulin receptor tyrosine kinase-catalyzed phosphorylation of 422(aP2) protein. Substrate activation by longchain fatty acid. J Biol Chem 1990; 265: 21075–85.PubMedGoogle Scholar
  10. 10.
    Khan WA, Blobe GC, Hannun YA. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cellular Signalling 1995; 7: 171–84.PubMedCrossRefGoogle Scholar
  11. 11.
    Crooke ST, Mattern M, Sarau HM, Winkler JD, Balcarek JD, Wong J, Bennett CF. The signal transduction system of the leukotriene D4 receptor. Trends Pharmacol Sci 1989; 10: 103–7.PubMedCrossRefGoogle Scholar
  12. 12.
    O’Flaherty JT, Chadwell BA, Kearns MW, Sergeant S, Daniel LW. Protein kinases C translocation responses to low concentrations of arachidonic acid. J Biol Chem 2001; 276: 24743–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Laurence Walch
    • 1
  • Xavier Norel
    • 1
  • Jean-Pierre Gascard
    • 2
  • Charles Brink
    • 1
  1. 1.2536 Hôpital BroussaisCNRS FREParisFrance
  2. 2.Centre Chirurgical Marie-LannelongueLe Plessis RobinsonFrance

Personalised recommendations